This multicenter study of patients after liver resection for hilar cholangiocarcinoma evaluates whether the number of positive lymph nodes or the lymph node ratio was most accurate for staging.
This study reports that patients with node-positive esophageal adenocarcinoma benefit significantly from neoadjuvant chemoradiation, while patients with node-negative tumors do not gain significant overall survival as compared with surgery alone.
This study of patients with colon cancer from the SEER database evaluated the effect of inclusion of C stage into standard cancer staging and the implications on survival estimates.
This cohort study observes characteristics associated with long-term survival of patients with pancreatic ductal adenocarcinoma and develops a nomogram to help identify potential long-term survivors.
Findings from this retrospective review show the importance of removing the less radioactive nodes in patients with cutaneous melanoma.
This review describes new technologies and treatment options that will continue to advance the treatment of rectal cancer by a multidisciplinary team.
Kadera and colleagues aimed to perform a detailed survival analysis of their institution’s experience with patients with locally advanced/borderline resectable pancreatic ductal adenocarcinoma who were downstaged and underwent surgical resection and (2) identify prognostic biomarkers that may help guide a decision for the use of adjuvant therapy in this patient subgroup. L. Andrew DiFronzo, MD, provided an invited commentary.
Leung et al reviewed the records of patients with cutaneous melanoma who underwent completion lymph node dissection to evaluate whether disease limited to sentinel lymph nodes represents different clinical significance than disease spread into nonsentinel lymph nodes. See the invited commentary by Leong.